SCHEMBL733148

SCHEMBL733148

CCOc1cc(C(=O)O)c(-c2cnn(C(F)F)c2)c(OCC)c1C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 1/20 0.33
TP53 P04637 1/20 0.32
PDE3B Q13370 2/20 0.31
PDE3A Q14432 2/20 0.31
NEK2 P51955 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31
CAMKK1 Q8N5S9 1/20 0.31
CAMKK2 Q96RR4 1/20 0.31
F11 P03951 2/20 0.30
KLKB1 P03952 2/20 0.30
JAK2 O60674 1/20 0.30
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CG P48736 1/20 0.30
CYP3A4 P08684 1/20 0.30
RET P07949 1/20 0.30
NOTUM Q6P988 1/20 0.30
ACLY P53396 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4563130 0.80 TSHR (0.36) TSHRHSD17B10MAPTTP53EGLN1
SCHEMBL730596 0.77 TSHR (0.41) TSHRMAPTEGLN1F11KLKB1
SCHEMBL733113 0.72 RET (0.37) TSHRPDE3BPDE3AF11KLKB1
SCHEMBL4540687 0.69 RET (0.34) TSHREGLN1F11KLKB1RET
SCHEMBL730763 0.68 KIT (0.37) JAK2PIK3CDPIK3CAPIK3CG
SCHEMBL4299370 0.65 TSHR (0.57) TSHRHSD17B10TP53CYP3A4
SCHEMBL16575399 0.63 TSHR (0.40) TSHRHSD17B10MAPTCYP3A4
SCHEMBL31318761 0.62 BAZ2B (0.45) TSHRHSD17B10MAPTTP53
SCHEMBL731308 0.61 MAP4K4 (0.45) TSHRMAPTEGLN1
SCHEMBL2828736 0.61 TSHR (0.75) TSHRHSD17B10TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 TSHR 680/4885HSD17B10 855/4885MAPT 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.